Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pharmacokinetics and pharmacodynamics of rosiglitazone in relation to CYP2C8 genotype.
Kirchheiner J, Thomas S, Bauer S, Tomalik-Scharte D, Hering U, Doroshyenko O, Jetter A, Stehle S, Tsahuridu M, Meineke I, Brockmöller J, Fuhr U. Kirchheiner J, et al. Among authors: jetter a. Clin Pharmacol Ther. 2006 Dec;80(6):657-67. doi: 10.1016/j.clpt.2006.09.008. Clin Pharmacol Ther. 2006. PMID: 17178266 Clinical Trial.
Effect of propiverine on cytochrome P450 enzymes: a cocktail interaction study in healthy volunteers.
Tomalik-Scharte D, Jetter A, Kinzig-Schippers M, Skott A, Sörgel F, Klaassen T, Kasel D, Harlfinger S, Doroshyenko O, Frank D, Kirchheiner J, Bräter M, Richter K, Gramatté T, Fuhr U. Tomalik-Scharte D, et al. Among authors: jetter a. Drug Metab Dispos. 2005 Dec;33(12):1859-66. doi: 10.1124/dmd.105.005272. Epub 2005 Sep 23. Drug Metab Dispos. 2005. PMID: 16183781 Clinical Trial.
Cytochrome P450 2C9 phenotyping using low-dose tolbutamide.
Jetter A, Kinzig-Schippers M, Skott A, Lazar A, Tomalik-Scharte D, Kirchheiner J, Walchner-Bonjean M, Hering U, Jakob V, Rodamer M, Jabrane W, Kasel D, Brockmöller J, Fuhr U, Sörgel F. Jetter A, et al. Eur J Clin Pharmacol. 2004 May;60(3):165-71. doi: 10.1007/s00228-004-0754-z. Epub 2004 Mar 25. Eur J Clin Pharmacol. 2004. PMID: 15045499
Clinical pharmacokinetics of trospium chloride.
Doroshyenko O, Jetter A, Odenthal KP, Fuhr U. Doroshyenko O, et al. Among authors: jetter a. Clin Pharmacokinet. 2005;44(7):701-20. doi: 10.2165/00003088-200544070-00003. Clin Pharmacokinet. 2005. PMID: 15966754 Review.
The effect of silymarin on oral nifedipine pharmacokinetics.
Fuhr U, Beckmann-Knopp S, Jetter A, Lück H, Mengs U. Fuhr U, et al. Among authors: jetter a. Planta Med. 2007 Nov;73(14):1429-35. doi: 10.1055/s-2007-990256. Epub 2007 Oct 30. Planta Med. 2007. PMID: 17968815 Clinical Trial.
Mesalazine pharmacokinetics and NAT2 phenotype.
Lück H, Kinzig M, Jetter A, Fuhr U, Sörgel F. Lück H, et al. Among authors: jetter a. Eur J Clin Pharmacol. 2009 Jan;65(1):47-54. doi: 10.1007/s00228-008-0550-2. Epub 2008 Aug 14. Eur J Clin Pharmacol. 2009. PMID: 18704388 Free article. Clinical Trial.
In vivo role of cytochrome P450 2E1 and glutathione-S-transferase activity for acrylamide toxicokinetics in humans.
Doroshyenko O, Fuhr U, Kunz D, Frank D, Kinzig M, Jetter A, Reith Y, Lazar A, Taubert D, Kirchheiner J, Baum M, Eisenbrand G, Berger FI, Bertow D, Berkessel A, Sörgel F, Schömig E, Tomalik-Scharte D. Doroshyenko O, et al. Among authors: jetter a. Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):433-43. doi: 10.1158/1055-9965.EPI-08-0832. Epub 2009 Feb 3. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19190172 Free article.
86 results